195 related articles for article (PubMed ID: 31971260)
21. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
22. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
23. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
24. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
25. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
26. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
27. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
28. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
29. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
30. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis.
Caini S; Boniol M; Botteri E; Tosti G; Bazolli B; Russell-Edu W; Giusti F; Testori A; Gandini S
J Dermatol Sci; 2014 Jul; 75(1):3-9. PubMed ID: 24680127
[TBL] [Abstract][Full Text] [Related]
31. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
Beroukhim K; Pourang A; Eisen DB
J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological analysis of second primary malignant neoplasms in cancer survivors aged 85 years and older: a SEER data analysis (1975-2016).
Zhao X; Zhang L; Bai L; Zhao Y; Yang Q
Sci Rep; 2022 Jul; 12(1):11688. PubMed ID: 35803964
[TBL] [Abstract][Full Text] [Related]
33. Second primary malignancies in patients with melanoma in situ: Insights from the surveillance, epidemiology, and end results program.
Ulanja MB; Beutler BD; Antwi-Amoabeng D; Cohen PR; Moody AE; Rahman GA; Djankpa FT; Gullapalli N; Boampong-Konam K; Macaire JK; Bowman AT; Baral S; Bowles DW
Cancer Epidemiol; 2021 Jun; 72():101932. PubMed ID: 33773145
[TBL] [Abstract][Full Text] [Related]
34. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
35. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
36. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
[TBL] [Abstract][Full Text] [Related]
37. Second cancers in patients with chronic lymphocytic leukemia.
Travis LB; Curtis RE; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
39. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
40. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
